| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 50 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 50 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 50 |
| 3 | METHOTREXATE SODIUM | 46 |
| 4 | METHOTREXATE | 45 |
| 5 | ETOPOSIDE | 38 |
| 6 | DOXORUBICIN | 32 |
| 7 | CYTARABINE | 31 |
| 8 | PREDNISONE | 31 |
| 9 | NELARABINE | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NELARABINE | 21 | 0.0216 |
| 1 | IDARUBICIN HYDROCHLORIDE | 6 | 0.0052 |
| 2 | DAUNORUBICIN HYDROCHLORIDE | 8 | 0.0049 |
| 3 | ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN | 1 | 0.0029 |
| 4 | THIOGUANINE | 4 | 0.0019 |
| 5 | TAZEMETOSTAT | 3 | 0.0018 |
| 6 | PEMIGATINIB | 1 | 0.0012 |
| 7 | CEFPODOXIME PROXETIL | 1 | 0.0010 |
| 8 | MITOXANTRONE HYDROCHLORIDE | 6 | 0.0010 |
| 9 | CLOFARABINE | 2 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 1 | Topoisomerase Inhibitor [EPC] | 38 | 0.0005 |
| 2 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 3 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 4 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 4 | 0.0003 |
| 5 | BCL-2 Inhibitor [EPC] | 17 | 0.0003 |
| 6 | Asparagine-specific Enzyme [EPC] | 3 | 0.0002 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 60 | 0.0002 |
| 8 | Parenteral Iron Replacement [EPC] | 3 | 0.0002 |
| 9 | Alkylating Drug [EPC] | 52 | 0.0002 |